Phosphodiesterase-4 activity: a critical modulator of atrial contractility and arrhythmogenesis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22676939.
- Also identified by DOI 10.1016/j.jacc.2012.03.027 and PMC identifier 3671593.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Atrial excitation-contraction coupling (ECC) and pacemaker activity are both dependent on intracellular calcium (Ca<sup>2+</sup>) cycling, and alterations in Ca<sup>2+</sup> cycling are strongly implicated in the pathophysiology of atrial fibrillation (AF). Depolarization of cardiac myocytes promotes Ca<sup>2+</sup> influx via L-type calcium channels (LTCCs), which then releases a larger quantity of Ca<sup>2+</sup> from intracellular stores. For ECC, elevated Ca<sup>2+</sup> interacts with troponin C, promoting cross bridge interaction and myocyte contraction. Relaxation during diastole requires intracellular Ca<sup>2+</sup> levels to return to baseline levels, either via reuptake of Ca<sup>2+</sup> into the sarcoplasmic reticulum or extrusion from the cell by the sodium calcium exchanger. In pacemaking cells, Ca<sup>2+</sup> influx via the LTCC underlies the upstroke of the action potential; Ca<sup>2+</sup> (and sodium) influx via HCN (hyperpolarization-activated cyclic nucleotide-gated) channels regulates the rate of diastolic depolarization.
Medical subject headings
- Arrhythmias, Cardiac
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Heart Atria